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Abstract 
 
This report aims to be the gathering of the main ideas that culminated in the presentation 
at the 1st Winter School of the PhD Programme on Technology Assessment (FCT-UNL) 
in December 2010. It is a guideline for future work development regarding Technology 
Assessment in Radiology, particularly having Magnetic Resonance Imaging, as an 
example. Therefore, as a background, it is necessary to understand what is “Technology 
Assessment”, how it developed and what it Europe’s interest in this area.  
Doing a transposition of this subject to health area, it is also important to understand the 
particularities of Health Technology Assessment. Portugal framework on this subject will 
also be addressed. As so, the Portuguese National Health System is characterized and 
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 Based on the report for the unit “Project III” of the PhD programme on Technology Assessment in 2011. 
The  unit was supervised by Prof. António B. Moniz (FCT-UNL). 
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the decision-making stakeholders identified, has well as the competences for the 
decision-making process in general. 
More generally, the different stakeholders perception involved in decision making, the 
mapping skills on technology assessment and decision making, the identification of 
indicators present in this decision making in Radiology, particularly in Magnetic 
Resonance area, are subjects to be addressed. To accomplish this, a research 
methodology was outlined, so that six research questions could be answered and five 
hypotheses could be accepted or refuted, in the future. With this research methodology, 
the Portuguese state of the art Magnetic Resonance equipment existence will be studied, 
using a survey as a resource. 
In the future, a mapping stakeholder technique will be used to identify the decision 
making key stakeholders and a survey will be applied to map theirs skills and 
competences in the process, where a pre-test was already applied. 
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1. Introduction 
 
We are facing an era, where pressures on health costs are extremely high, and the reforms in 
health system are almost constant. But over time, one factor remains unchanged: technology 
continues to be the support of health care improvement. Radiology is with no doubt, a clear 
example of technology application in order to obtain the medical examination of a patient. 
Radiology is also certainly a clear example of the application of technology to obtain exams of 
high importance in the diagnosis and the medical decision process, and treatment of numerous 
pathologies. 
However, within this variety of existing technologies related with Radiology, one stands out ... 
Magnetic Resonance Imaging (MRI) differs from other imaging techniques, since it allows to 
obtain axial, coronal and sagittal images. It has also a high sensitivity to fluids movements, 
including blood and cerebrospinal fluid. This can be critical for an accurate medical examination. 
And MRI does not use x-rays radiation to obtain the images, since the images of tissues are 
based on their own physical and biochemical properties and there is some easiness in 
observing tissue surrounded by bone structures (cf. Tavares 1999). 
Predicting the future of MRI exams is a speculative exercise, however it is easy to predict that 
this equipment will have a very exciting future with many benefits for users (patients). The 
accuracy can be improved to a much higher range, safety for the radiology technicians can be 
much improved, equipment maintenance can be easier and the usage costs can be better 
controlled. 
But all of these only make sense, if it is considered in a Technology Governance (TG) 
environment, seen as a set of policies undertaken by the public and private sector and society 
actors in a given space in time to develop a knowledge base, social cohesion and 
competitiveness at the sometime2.  
A participatory methodology is considered in TG so that the opinion of the different actors can 
be taken into account. The identification of these actors (or decision-makers) is for that, 
extremely important and needed. These actors (citizens included) must be engaged and treated 
equally and given the some opportunity of participation. All actors must be responsible and 
participate with most transparency. Regarding the health sector, citizens (seen as potential 
patients) must be better informed and knowledge based, so that they can be more participative 
in their own health management and there for, more responsible. This is the proposal of the 
Technical Group for the Hospital Reform in the paper “Final Report - Citizens in the centre of 
the system. Professionals in the centre of change”.3 One of the fundamental pillars 
of strengthening the role of users in health care relates to the ability of this influence decisions 
about health care, ie, the ability of users to access information, that it be clear and 
transparent, and that it will allow conscious and informed options and for that more demanding 
and driving quality and efficiency of services provided. Thus, the availability of 
information strongly conditions the user involvement in decision making. (Grupo Técnico para a 
Reforma Hospitalar 2011) 
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 See Tallinn University of Technology - Technology Governance website at http://hum.ttu.ee/tg/  
3
 See: http://www.portaldasaude.pt/NR/rdonlyres/84FCFCE2-3C84-4ABE-8E5F-
AD4DDB0B46F4/0/RelatorioGTRH_Nov2011.pdf 
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Another recommendation is also made by this Technical Group, has the role of the citizen, as 
the focal point of the health system should be strengthened to ensure that the entities that 
comprise the health system act in function of the citizen, by adjusting their behaviour to 
the actual needs of this, instead of the current situation of the health system, in which the citizen 
will have to adjust the provision of health care. With this new framework, the health system can 
be characterized by providing citizens accessibility to up-dated and consistent information, both 
regarding the health system and health information and by enabling citizens to be able to make 
informed and conscious decisions about their health, through the joint decision-
making with health professionals. 
If, ultimately, the decisions made in health care will affect the citizens (patients or not) it is 
expected that they have a say in the process. This is why, the new health politics tend to be 
more focused on patient and engage their involvement, perceptions and expectations. Like 
Facey et al say, “if we have moved to an era where patient’s work in partnership with their 
health professional, rather than as the passive recipients of healthcare, it is reasonable that they 
participate in the Health Technology Assessment process” (Facey et al. 2010). According to 
Antunes (p. 136) the access to information is an unquestionable right, that goes along with the 
informed consent (Antunes 2001). 
Citizens also must have a say in health technology assessment (HTA) area. HTAi (see 2.2.1 
chapter) Interest Group on Patient /Citizens Involvement in Health Technology Assessment was 
created in 2005 and seeks to encourage and share best practice in engaging with patients and 
citizens throughout the HTA process and to promote methods of obtaining robust evidence for 
assessment of patient’s perspectives. 
 
 
2. Theoretical Framework 
2.1. Technology Assessment 
Starting with the definition of some important concepts, this chapter addresses the history and 
development of Technology Assessment (TA), first in the US and Europe. Different types of TA 
will also be mentioned, with special interest in Participatory TA. The aim of this chapter is to give 
a general main idea concerning TA contextualization.  
 
2.1.1. What is Technology Assessment? 
In 1996 US House of Representatives Subcommittee on Science, Research and Development 
published a report on the side-effects of technological innovation, which included a request for 
establishing an early warning reveal the positive and negative effects of technology probably in 
this report that the term ‘technology assessment’ was officially used for the first time (Tuininga 
1988) under the chairman of Emilio Daddario. According to Arnstein (1977) and Coates 
(1971,1977), in early studies on technology assessment, it was defined as a form of policy 
research that examines short- and long- term consequences (for example, societal, economic, 
ethical, legal) of the application of technology (David Banta 2009). 
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According to the TAMI report (Europäische Akademie 2004) and to Bütschi, Decker and 
colleagues (Bütschi et al. 2004), TA is considered a scientific and communication process, 
which aims to contribute to the formation of public and their political opinion on social aspects of 
science and technology, and for that it is necessary to go further than mere economic studies. 
 
2.1.2. The development in Technology Assessment 
 
In the years following 1966 the methodology, practice and institutionalization of the objectives, 
basic concepts, working means and the prospects for formal recognition of TA have been put 
into concrete terms. Many TA studies were carried out and Congress’s Office of Technology 
Assessment (OTA) was established by the Technology Assessment Act of 1972 (Tuininga 
1988). The OTA was an office of the U.S. Congress from 1972 to 29 September, 19954. OTA’s 
purpose was to provide Congressional members and committees with objective and 
authoritative analysis of the complex scientific and technical issues of the late 20th century 
(David Banta 2009). 
In 1980, Donald Lambro criticised OTA, calling it an “unnecessary agency” that duplicated 
government work done elsewhere. These critics were favoured by the Reagan administration. 
OTA was closed on September 29, 1995 (David Banta 2009). Regardless its closure, OTA 
served as an example and as a stimulate activity in TA for other American and also international 
institutions. The technology assessment movement soon spread to other countries, especially 
the highly developed industrialized countries, where it gained an increasing degree of influence 
in political debates on research and technology (Tuininga 1988). 
 
2.2. Health Technology Assessment 
 
The main objective of these sub-chapter is to make a thematic framework for HTA, using the 
definition of some key concepts. It is also intended to make the state of the art of HTA in 
Portugal, as well as addressing the evolution of this methodology around the world. 
 
2.2.1. What is HTA? 
One of the main challenges in health care is to improve the quality of health systems. For that it 
is necessary to establish mechanisms for transferring knowledge to action, therefore HTA can 
be a tool in the broad challenge of bridging the Know-do (or How to do) gap in health care 
management (HTAi and INAHTA). With the development of HTA, some Agencies and 
Institutions started do appear. 
INAHTA is the acronym for International Network of Agencies for Health Technology 
Assessment, a non-profit organization established in 1993 and has now grown to 53 member 
agencies from 29 countries including North and Latin America, Europe, Africa, Asia, Australia, 
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and New Zealand. All members are non-profit making organizations producing HTA and are 
linked to regional or national government. Many organizations throughout the world assess 
healthcare technology. There is an evident need to cooperate and share information from 
different cultures. INAHTA serves this purpose.5 
HTAi is the global scientific and professional society for all those who produce, use, or 
encounter HTA. HTAi embraces all stakeholders, including researchers, agencies, 
policymakers, industry, academia, health service providers, and patients/consumers, and acts 
as a neutral forum for collaboration and the sharing of information and expertise. With members 
from 59 countries and six continents, HTAi is a thriving global network. HTAi is actively 
committed to international collaboration, and has signed formal Memoranda of Understanding 
with the World Health Organization and the International Network of Agencies for HTA 
(INAHTA).6 
HTA can be understood, according to the International Network of Agencies for Health 
Technology Assessment, as a multidisciplinary field of analysis and decision, which studies the 
implications of clinical, social, ethical and economic development, dissemination and use of 
health technologies, without neglecting its political analysis (Goodman 2004). 
According to HTAi and INAHTA, HTA is the systematic evaluation of properties, effects or other 
impacts of health care intervention and may address the direct and intended impacts or 
consequences of interventions, as well as their indirect and unintended ones. According to 
these two organizations, the main purpose of HTA is to inform decision making in health care, 
including decisions made at the individual or patient level, the level of the health care provider or 
institution, or the regional, national and international levels. HTA is conducted by 
interdisciplinary groups using explicit analytical frameworks and drawing from a variety of 
methods. 
Initially, HTA was restricted to the assessment of new “technologies”, but over the years its 
focus has expanded to address questions from all levels of decision making in health care. HTA 
can assess interventions on four levels: the technology level, the individual / patient level, the 
population level and the policy level (HTAi and INAHTA). Since HTA focus on health 
technology, it is important to understand what health technology refers to. According to the HTAi 
and INAHTA, health care technology refers to drugs, biologics, devices, equipment, supplies, 
medical and surgical procedures, support systems, and organisational and managerial systems. 
HTA addresses the different applications of an intervention, including prevention, screening, 
diagnosis, treatment and rehabilitation. It is not a one-time evaluation. Rather, it may be applied 
throughout the lifecycle of a technology, from the design and investigational stages, to standard 
or established use, and to obsolescence or disposal (HTAi and INAHTA). 
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 From: http://inahta.episerverhotell.net/Home/ (accessed on 25.01.2012) 
6
 From: http://www.htai.org/index.php?id=428 (accessed on 25.01.2012) 
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2.2.2. Technology Life cycle 
 
Since the moment a technology is introduced into the market, until the time that it is replaced or 
it becomes obsolete, a whole life cycle happens. The natural life-cycle of technologies in health 
care can be represented in the next figure: 
 
Figure 1 - Diffusion of health technologies 
(Source: adopted from WHO, 2011) 
 
The life cycle of a technology begins with the process of Research and Development (some 
authors name it “Innovation”). The following phase is the phase to experiment the technology or 
when “early adopters” try to use the new technology, as an experiment, which determines the 
degree of acceptance of the new technology. According to the World Health Organization 
(WHO) this phase can also be called “experimental technology” (World Health Organization 
2011). 
As time goes by and as a reflex of the continued use and possible dissemination, the 
technology is established and starts to gain confidence by users, in a larger market dimension. 
This confidence is confirmed with the reimbursement or refund of practice behind the 
technology. This phase is also a way to strengthen the implicit benefits that technology can 
bring to society. This phase is called “Innovative technology”, also according to WHO. 
Subsequently, it is expected that the market refers to the new technology on a larger scale – 
“general use” – but that isn’t always the case. Sometimes, it appears that the technology is 
underused and it is not profitable. There are many reasons for this reality, for example, a miss-
location of resources, unequal access to technology, and lack of professionals able to work with 
technology. Over-estimations of market dimensions or social utility can also explain the under 
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usage of such technology. Such reality can be applied to any technology in any region or sector, 
or even in any kind or organization. 
The life cycle of a technology ends with the abandonment. At this stage the technology is put 
aside, because it has become obsolete or ineffective. Or even because companies need to 
strategically exit the market. That is the “Obsolescence and Replacement” phase, when a 
specific technology must be replace by a new one (developed by the same company, or by 
another one). 
Taking into account the life cycle of a given technology, TA studies can give a huge contribution 
in the process of decision making. TA studies should not be made only once during a 
technology life cycle. Instead, these studies should be carried out along all technology life cycle, 
as shown in Figure 2. As an example, prior to the incorporation of technology in the health 
system, an initial assessment process should be made, for instant from an economic point of 
view (production costs). Other types of studies should also evaluate the advantages and 
disadvantages, benefits and risks and also the impacts of implementing these new 
technologies. Taking MRI equipment for example: there are different models of MRI machines, 
developed by different firms. In the end, some of the MRI characteristics are the same. For 
instant, the strength of a magnet in an MRI system is rated using a unit of measure known as 
Tesla (T). The magnets in use today in MRI systems create a magnetic field of 0.5-T to 3T (note 
that the Earth's magnetic field measures 0.00005T, so this make possible to see how powerful 
these magnets are).This are the MRI equipment in the market, at present days, however studies 
are also being made for the market introduction of the 7 and possible 10T. 
This first phase of evaluation is limited, since it only allows quantifying the impacts that are 
observed after the initial diffusion of new technology. TA studies performed at this stage, allow 
the decision-maker to provide a series of new data that will help him to make the right decision, 
for example, over the incorporation (or not!) of a certain technology in the market. 
 
 
Figure 2 - Health technology assessment and diffusion of health technologies 
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         (Source: WHO, 2011) 
 
When a new medical technology is introduced in the market, it becomes clear that there is a 
need to assess the problems that may emerge, with such introduction. Usually, when it 
happens, hospitals or health institutions are not quite ready to handle this issue. That is why 
assessment teams are needed and put together, to develop HTA reports on this matter. 
The introduction of MRI into clinical practice was a clear example of this matter. We can take as 
an example the case of Switzerland. In Chrzanowski and Gutzwiller paper we can realize that, 
to handle with the problems raised by the introduction of new medical technologies, two non-
governmental institutions were created: The Swiss Hospital and Public Health Institute (SHI) 
and the Association of Swiss Hospitals (VESKA). This new institutions were called to study 
special health emerging problems, and among them, new medical technology (cf. Chrzanowski 
and Gutzwiller 1986). 
A panel of experts (including representatives of diagnostic radiology, biochemistry, medical 
physics, social medicine and epidemiology, universities, insures companies, etc.) prepared a 
report on MRI, where it was established the need for this kind of technology in the country and 
the number of sites of MRI systems in the capital, running and unitary costs on this diagnostic 
procedure were also estimated. This kind of HTA study helped planning investments and also 
helped to deal with reimbursements and other issues on health care policy, so new 
recommendations start to appear. 
If we now think in the final phase of the life cycle of technology, the decision-makers (further on 
designated as DM) have, once more, to make a decision concerning the abandon or 
replacement of a certain technology. HTA reports can be helpful when this kind of decision has 
to me made. 
As we said before, health technology assessment should be a practice along health technology 
life cycle, since many problems can be defined along this life cycle. In their paper, Chrzanowski 
and Gutzwiller listed some problems along technology health cycle: funding, reliability, safety, 
control of standards, etc., that we now schematize in   Table 1 (cf. Chrzanowski and Gutzwiller 
1986).  
 
Stages Problems 
Research and development - Funding 
- Reliability 
Experimental technology - Safety 
- Efficacy 
Innovative technology - Safety 
- Effectiveness 
- Cost 
- Initial Evaluation 
General use - Long-term side-effects 
- Outcome 
- Efficiency 
- Standardization and Stability 
- Reimbursement 
- Complete Evaluation 
Obsolescence / replacement - Control of Standards 
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- Comparison with emerging technologies 
- Funding of modification 
- Replacement 
Table 1 – Stages in the diffusion of health technologies and the occurrence of some problems 
 
On one hand, the political decisions made and based on HTA reports should take into account 
scientific evidence, linking efforts between the technical, economic and political dimensions, 
using a participatory vision, so that it can be translated in the best possible decision (cf. Novaes 
2006). On the other hand, the success of such decisions depend critically on the skills of the 
researcher to convey wisdom and confidence in applying rules of argumentation (cf. Armin 
Grunwald 2007), thus it is of utmost importance to identify all potential decision makers involved 
in technology assessment process. 
For this matter, the identification of DM (also referred as stakeholders or actors), activities and 
priority settings for HTA in Portugal, is needed on a national level. Following the example of 
other countries who already made this data collection, as for example, Netherlands (cf.  Oortwijn 
et al. 1999), US (cf. Perry and Thamer 1997), France (cf. Stephan 1988), lessons can be 
learned from others and experiences studied. With the purpose of understanding the need for 
co-ordinated efforts in this area, different further on designated as DM can become and work as 
team, and also some sharing experiences can be promoted. This data gathering is very 
important for a balanced TA process. 
 
2.2.3. Europe’s interest in Health Technology Assessment 
 
Meanwhile, in Europe, TA issues were also a subject of interest. OECD published several 
papers and books on TA between 1974 and 1983, and a numerous organizations have 
benefited from TA discussion, carried out TA-like studies and developed TA-like procedures. An 
inventory of these experiments was drawn up by the Dutch Organization for Applied Scientific 
Research (TNO). Based on this inventory the authors show that a new wave of TA 
institutionalization has occurred in Europe. Different forms of TA institutionalization are 
presented in which choices have to be made with regard to the political, executive and scientific 
organization of TA. How and when these choices are made depends on the constitutional and 
political structure and traditions of the particular country. Therefore, four main variants emerged: 
governmental TA institutes, parliamentary TA institutes, independent TA institute and combined 
forms of institutionalization (Tuininga 1988). 
One special area subject of TA was health care. In fact, one of the first reports from OTA was 
related to TC scan. It was the beginning of HTA. The European interest in HTA dated back to 
the late 1970’s, with the growing interest on economic aspects of health technologies (Johnson, 
2002 cited in Velasco-Garrido and Busse 2005). 
Regarding the scope and types of assessment, according to Garrido et al. (2008) in the first 
year of HTA in Europe, the few existing agencies concentrated mainly, on the assessment of 
procedures as medical devices. As an example, we can find pre operative diagnostic routines 
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and their use in Sweden assessment report by SBU7, as their first HTA report in 1989 
(Arvidsson et al. 1989 cited in Garrido et al. 2008). 
Another example can be identified in Catalan Agency for Health Technology Assessment and 
Research8 who, in the first report evaluated the procedure for ambulatory surgery (Espiràs et al., 
1992 in Garrido et al. 2008). 
As health medicine and the health care procedures evolved, so does the scope of HTA. 
Nowadays we can assist to a variety of assessments, that include medicines, procedures, 
devices, interventions... Not only the scope, but the type of assessment have also evolved. We 
have assisted in the begining (before formal institutionalization of HTA) to capital – intensive 
technologies and costly pharmaceuticals assessments (cf. Banta and Jonsson, 2006 cited in 
Garrido et al. 2008). To clinical aspects of technologies that dominate the majority of 
assessments (Garrido et al. 2008). However, organizational and societal issues have not 
generally been assessed with the same depth (Means et al. 2000; Draborg et al. 2005 cited in 
Garrido et al. 2008). 
  
2.2.3. Health Technology Assessment in Portugal 
 
Regarding the development of HTA programmes in the European Union, Banta and Oortwijn 
(2001) established an overview of HTA activities in 16 European countries. These programmes 
have been established during the last decade or so. According to their paper, the countries that 
began to assess health technologies in the early 1970’s and that can be considered leaders are 
Sweden and Denmark, and also Spanish province of Catalonia which established a committee 
on health technologies in 1984. Some countries established or designated national programmes 
to become involved in HTA, like Sweden (1987), France (1990), the United Kingdom (1990), 
Spain (1994), Finland (1995) and Denmark (1997). Others, like Portugal, when regarding HTA, 
just made, so far, some studies and analysis in the field. However, it is possible to assist to a 
growing interest in this matter, as the discussion of establishing a national HTA agency is taken 
into account (David Banta and Oortwijn 2001) 
In the search made, only one article addressed directly the relation between HTA and Portugal, 
as the main focus. It was published in the year 2000. In this paper, we can read that “Health 
technology assessment (HTA) is not very developed in Portugal”, although “there is presently a 
growing interest in HTA in Portugal”. This statement was said by Pinto, Ramos and Pereira on 
their paper in the year 2000. This paper reports on the status of HTA in Portugal. Their position 
was corroborated by the intentions of the Ministry of Health, who in the future was planning “the 
                                               
7
 SBU is the Swedish acronym for the Swedish Council on Technology Assessment in Health Care.  established in 
1987 by the Swedish Government to answer these and similar questions on behalf of the healthcare sector. Initially, 
SBU was an agency under the Swedish Government Offices. 
In 1992, SBU was commissioned as an independent public authority for the critical evaluation of methods used to 
prevent, diagnose, and treat health problems.  (in: http://www.sbu.se) 
 
8
  CAHTA was the Catalan acronym for Catalan Agency for Health Technology Assessment and Research.The 
former CAHTA broadens its functions and it is now denominated Catalan Agency for Health Information, Assessment 
and Quality (CAHIAQ). The CAHIAQ has now the mission of generating relevant knowledge to contribute to the 
improvement of the quality, safety and sustainability of the Catalan Health Care System and thus easing the decision-
making process for citizens and health care managers and professionals.(in: http://www.gencat.cat) 
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creation of a national (or regional) agency responsible for HTA, where economic evaluation 
studies will be a fundamental part of the assessment” (Pinto, Ramos, and Pereira 2000). 
Eleven years went by and the reality stays the same. The main idea persists... “It is critical to 
move forward towards the creation of a national agency of health technologies assessment, 
independent of political power, with technical and scientific autonomy, appropriate and highly 
qualified. This entity, in line with best international practices, would have the best conditions to 
assess and for innovation involving the parameters of the cost-effectiveness the principle of 
cost-opportunity and taking into account the limited resources and the need to qualify the 
choices”9, states Adalberto Campo Fernandes, on the chapter “The health policies” of his new 
book (Fernandes 2011). This book gathers three essays from three different authors and by 
that, three different perspectives for the health future in Portugal.  
Economic evaluation of health technologies is not done in a systematic, integrated, coherent 
manner. There are economic evaluation studies in areas such as pharmaceuticals, heavy 
equipment, and medical devices, but in practice they are very few. Policy decisions are not 
based on systematic assessments. In the pharmaceutical area, criteria for exclusion of 
reimbursement for a new drug are excessive cost and lack of evidence of therapeutic efficacy in 
comparison with similar reimbursed drugs. Excessive cost is determined by comparing the price 
of the new drug to the price of the cheapest similar reimbursed drug (excluding generics). In 
fact, this procedure involves a comparative analysis of therapeutics, and identifies, measures, 
and compares costs and effects of two alternatives. This is one of the few areas where such 
evaluation is carried out in Portugal (Pinto, Ramos, and Pereira 2000). 
According to the same authors, “The field of HTA is only now emerging in Portugal. Economic 
evaluations in areas such as pharmaceuticals, heavy equipment, and medical devices have 
begun to be carried out in the past few years, but their impact on policy is uncertain.” 
In a more recent report concerning Portugal health system, by the European Observatory on 
Health Systems and Policies and Nova School of Business and Economics, it is stat that 
Portugal does not have a tradition of HTA, with the exception of pharmaceutical products.. Since 
1988 the Ministry of Health has authorized the procurement and installation of expensive 
medical technologies in the public and private sectors. In 1995, new legislation lifted the 
restrictions on computerized (axial) tomography (CT) and magnetic resonance imaging (MRI) 
scanners. There are currently no effective methods for regulating the distribution of health 
equipment in the private sector. Most expensive medical equipment (67%) is located in the 
private sector, which is more flexible and innovative and therefore outstrips the public sector in 
the acquisition of high-technology equipment. Hospitals contract with private clinics for the use 
of equipment, providing a strong incentive for this provision pattern to continue (Barros, 
Machado, and Simoes 2011). 
According to the same authors, medical devices are regulated by law – Decree nº 145 / 2009, 
which determines that the INFARMED (National Authority of Medicines and Health Products) is 
the entity responsible for the surveillance of all medical devices. This Law-Decree establishes 
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 In the original: “é fundamental avançar no sentido da criação de uma agência nacional de avaliação de tecnologias 
da saúde, independente do poder político, com autonomia técnica e científica, idónea e altamente qualificada. Esta 
entidade, em alinhamento com as melhores prácticas internacionais, teria as melhores condições para avaliar a 
inovação associando aos parâmetros de custo-efectividade o princpio de custo-oportunidade e tendo em conta a 
limitação de recursos e a necessidade de qualificar as escolhas.”  
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rules about R&D, manufacturing, sales, entry, surveillance and advertising. This document 
adopts the EU Directive nº 2007 / 47 / CE to Portuguese legislation. 
In the some report, the authors conclude that, currently there is no economic evaluation applied 
to medical devices and mainly there is clearly room for further efficiency gains in the delivery of 
health care in Portugal, where the role of HTA is currently limited to pharmaceutical products. 
2.3. Decision Making 
 
This chapter aims to give a general elucidation on decision-making matters. A brief introduction 
of decision-making general aspects will be defined, followed by the competences necessary to 
be able to conduct a good decision-making process. 
 
2.3.1. Competences for Decision-Making 
 
The decision maker needs to evaluate the effectiveness and efficiency of a given technology, 
with variable costs and limited resources available during the decision-making process for the 
acquisition of such technologies. In health area, prior to taking any decision on the technology 
assessment, the decision maker must take into consideration some issues such as: 
• From the technologies available in the market, which ones can meet the needs of the 
population (in general)? 
• Will the technologies - identified as necessary for the general population - generate the 
expected benefits? 
• What are the health gains for the population, with the implementation of the 
technology? 
• Is there enough resources (financial, economic, human...) available and will they be 
sufficient to provide and maintain the technology (equipment, software, protocols, etc.) to 
all who eventually be need it? 
• Do social and ethical issues have been taken into account, when technological 
resources are being allocated? (population needs, geographical localization for the new 
equipments, existing nearby equipments for example) 
To answer to these questions, decision makers need to support their answers in HTA studies, 
since those studies provide a set of HTA information, reliable and synthesized on the effect and 
costs of health technology. 
According to the "White Paper on Education and Training" of the European Commission there 
are some factors that have boosted the possibilities of access the information and knowledge 
for people, but simultaneously as a consequence, led to changes in work organization and skills 
learned. These factors relate to the internationalization of trade, the global context of technology 
and above all the emergence of the information society (European Union 1995). 
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This reality can be seen in the area of radiology, specifically the MRI, because it is an area of 
constant and rapid technological change, since this is an increasingly complex system at 
various levels, which requires constant updating knowledge, a therefore skills, by the 
professionals who deal with it and work with it. 
The "White Paper on Education and Training" also makes a remark, as a consequence of this 
new reality, some people go through situations of exclusion (European Commission 1995). For 
this not to happen, in a Radiology Department, in the Magnetic Resonance  area (and beyond!) 
professionals must keep their knowledge updated, since at present it  is ease of access to 
information so that they won’t be excluded from dealing with this imaging technique. But it is not 
enough to study and develop these skills. There are other skills that should be developed so 
that professionals do not take the risk of being (by themselves or others) alienated from this 
technique. Thus, after the identification of key DM involved, it becomes interesting to 
understand and identify the skills that this decision makers hold to be considerate as such. 
According to Maia e Moniz, "competence" can be defined as a set of skills, abilities, related 
knowledge and attributes that enable an individual to perform a task or an activity within the 
course of their work (Maia and Moniz 2011). In the same way, the International Labour 
Organization - ILO definition refers to competence as an "ability to articulate and mobilize the 
intellectual and emotional conditions in terms of knowledge, skills, attitudes and practices 
necessary to perform a particular function or activity, in an efficient, effective and creative way, 
according to the nature of work " (Organização Internacional do Trabalho 2002). The ILO also 
refers that competence must be understood as "the ability to mobilize acquired knowledge and 
emotions to make decisions, to solve new problems and building work in a creative way “since 
the knowledge of today are in line with reality not mass production (as opposed to the origin of 
production Taylorism and Fordism honoured) and flexible work (Organização International do 
Trabalho 1999). 
In health systems, the World Health Organization defines competence as "capabilities, skills, 
knowledge, behaviours and attitudes that are fundamental to the achievement of desired results 
and therefore performance at work " (World Health Organization 2005). 
Competencies are operationalized at the level of "Knowledge." The knowledge can be 
described as: knowledge per se, how to do, how to be and how to learn, which correspond 
respectively to the skills acquired in training, the skills acquired in the performance of the 
profession, to attitudes that the professional assume in his daily life and cognitive abilities that 
allow to learn, think and process information. The relationship between the different 
"knowledge" was sketched in Figure 3. 
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Figure 3 - Schematization between the different "knowledge" and Skills 
               (Source: Adapted from UNIDO 2002) 
 
These knowledge are closely related to each other, forming a set of knowledge, that the 
professional will acquire and develop throughout his activities, so throughout his professional 
life, as he modifies his competences. 
Despite the methodology used in HTA, the decision-makers involved, or the types of 
technologies assessed, a certain degree of uncertainty will always persist in the decision 
process. It is up to the decision-maker to accept the existence of this uncertainty and the level of 
arbitrariness in the choices made (cf. Stephan 1988). However, technology assessment studies 
tend to reduce uncertainty in decision-making process, by providing full evidenced information 
on a given matter. But they aren’t one hundred per cent uncertainty free. 
 
3. Portuguese National Health System 
 
In this chapter is intended to make a framework of the Portuguese Health System, aiming to 
have a better framework for characterizing the distribution of MRI technology in the country. It is 
on the best interest to understand who makes up the system - Health Stakeholders - in what 
way and how does it relates to other entities. 
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3.1. NHS Characterization 
 
In the paper “Health Technology in Portugal”, Pinto, Ramos and Pereira, make a very explicit 
resume regarding Portuguese NHS. According to the authors, the Parliament determines the 
total budget of the NHS. The Minister of Health is responsible for the definition of the national 
health policy and the promotion and surveillance of its execution. The Ministry of Health is 
responsible for regulating, coordinating, planning, evaluating, and inspecting the services of the 
NHS. Responsibility for the functioning, organization, and management of the NHS is shared by 
the Ministry of Health and five Regional Health Authorities. The Regional Health Authorities are 
responsible for the planning and distribution of resources and the coordination and evaluation of 
hospital and health centre activities in their regions. The health system includes the NHS and all 
the public entities with activities in health promotion, prevention, and treatment of disease, as 
well as private entities and professionals that contract with the NHS to provide health services. 
The NHS includes all the public healthcare providers that depend on the Ministry of Health 
(Pinto, Ramos and Pereira 2000). 
The 1979 legislation stated that the private sector should complement the public sector by 
providing health care in areas that could not be served by the public sector. NHS patients 
referred to private healthcare providers normally do not pay for the service delivered. Providers 
are reimbursed directly by the NHS. 
 
3.2. Health Stakeholders and the Administration of the System 
 
Before we can understand the process of decision making it is important that the decision -
makers (or stakeholders) can be identified. 
The identification of DM (also referred as stakeholders or actors), activities and priority settings 
for HTA in Portugal, is needed on a national level. Following the example of other countries who 
already made this data collection, as for example, Netherlands (cf. Oortwijn et al. 1999), US (cf. 
Perry and Thamer 1997), France (cf. Stephan 1988), lessons can be learned from others and 
experiences studied. With the purpose of understanding the need for co-ordinated efforts in this 
area, different DM can become and work as team, and also some sharing experiences can be 
promoted. This data gathering is very important for a balanced TA process. 
A recent report from Deloitte, states that primary health care institutions as well as secondary 
and continued care institutions are at the present the NHS basis as well as of the all health care 
system, cohabiting with the private and social health entities. In a very explicit way, Deloitte 
represented those hey stakeholders as we can see in Figure 4 (Deloittte 2011): 
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Figure 4 - Key Stakeholders in the Portuguese health sector 
             (Source: Delloitte, 2011) 
 
4. Investigation Context - The MRI 
 
In 1946, Block and Purcell developed the principles of MRI, which earned them the award of the 
Nobel Prize for Physics in 1952. Later in 1951, Gadillard demonstrated that it was potentially 
possible to obtain spatial locations with MRI. In 1975, the first prototype of a magnet for 
commercial purposes is developed, and from 1980 to 83 the first publications of clinical studies 
appeared (Tavares 1999). MRI differs from other imaging techniques, since: 
● allows axial, coronal and sagittal imaging; 
●  has a high sensitivity to the movement of fluids (including blood and cerebrospinal fluid);  
● does not use x-ray radiation to obtain images, since tissue images are based on their 
own physical and biochemical properties;  
● there is some ease of observation of tissue surrounded by bony structures (particularly 
in the posterior fossa and spinal cord). (Tavares, 1999) 
 
In terms of hardware, the basic hardware components of all MRI systems are the magnet, 
producing a stable and very intense magnetic field, the gradient coils, creating a variable field 
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and radio frequency (RF) coils which are used to transmit energy and to encode spatial 
positioning. A computer controls the MRI scanning operation and processes the information. 
The range of used field strengths for medical imaging is from 0.15 to 3T. The open 
MRI magnets have usually field strength in the range 0.2 T to 0.35T. The higher 
field MRI devices are commonly solenoid with short bore superconducting magnets, which 
provide homogeneous fields of high stability. There are these different types of magnets: 
resistive magnet, permanent magnet and superconducting magnet. 
The majority of superconductive magnets are based on niobium-titanium (NbTi) alloys, which 
are very reliable and require extremely uniform fields and extreme stability over time, but require 
a liquid helium cryogenic system to keep the conductors at approximately 4.2 Kelvin (-
268.8 Celsius). To maintain this temperature the magnet is enclosed and cooled by 
a cryogen containing liquid helium (sometimes also nitrogen). 
The gradient coils are required to produce a linear variation in field along one direction, and to 
have high efficiency, low inductance and low resistance, in order to minimize the current 
requirements and heat deposition. A Maxwell coil usually produces linear variation in field along 
the z-axis; in the other two axes it is best done using a saddle coil, such as the Golay coil. 
The radio frequency coils used to excite the nuclei fall into two main categories; surface 
coils and volume coils. The essential element for spatial encoding, the gradient coil sub-system 
of the MRI scanner is responsible for the encoding of specialized contrast such 
as flow information, diffusion information, and modulation of magnetization for spatial tagging. 
An analogue to digital converter turns the nuclear magnetic resonance signal to a digital 
signal10. The digital signal is then sent to an image processor for Fourier transformation and the 
image of the MRI scan is displayed on a monitor. 
However, this technique presents some disadvantages. Due to the high magnetic field it has 
and the size of the magnet tunnel, some patients are contra indicated to perform such exam in 
particular, patients with pacemakers, metallic prostheses not compatible, claustrophobic 
patients, patients with morbid obesity. 
It is not an easy task, to assess magnetic resonance imaging since it includes aspects of 
epidemiology, bio-statistics, clinical efficacy determination, outcomes assessment and 
knowledge of the technical and medical bases of imaging method (Thornbury and Fryback 
1992). There are too many different knowledge fields to tackle. Also that means such 
assessment process should always involve different scientific and technical competences. 
In 1997, Fireberg et al. proposed a hierarchical conceptual framework for use in the evaluation 
and comparison of diagnostic imaging for imaging tests. According to Gazelle and colleagues 
(cf. Gazelle et al. 2005), this approach was later adopted and modified by others, such as 
Fryback (1983), Fryback et al. (1991), Dixon (1997) and Hunink (1998). This model however, 
wasn’t new, since it has been described In the early 1970’s parts of the levels began to de 
described and its earliest form was published in a paper by Fryback in 1983 (Thornbury and 
Fryback 1992). Such model also can serve as a structure for a design of scientific research that 
can be achieved to assess the impact and usefulness of MR imaging. In a simple way, this 
hierarchical model, takes into account six levels of efficacy according to Fryback and Thornbury 
(1992): 
                                               
10
 From: http://www.mr-tip.com/serv1.php?type=dev 
21 
 
1. Technical 
2. Diagnostic accuracy 
3. Diagnostic thinking 
4. Therapeutic 
5. Patient outcome 
6. Societal. 
 
This kind of hierarchical model can be applied, for example, in the assessment of the 
technology for functional imaging cancer (cf. Laking, Price, and Sculpher 2002). Manufacturers, 
clinicians, patients, therapeutic and diagnosis technicians, hospital managers, government 
leaders, among others, either in the public or private sector, are increasingly demanding for the 
sustained demand of information to support their decisions. Such decisions can cover aspects 
as if a certain technology can be developed or how it will be done, or even whether a technology 
should or should not enter the market, or even if a certain technology should be acquire, 
transferred and/or used. 
This demand is well implied in the growth and development of HTA. Regarding MRI technology, 
HTA can be used in different types of health care decision-making as one or more properties, 
impacts or other attributes of this health care technology or its application can be assessed. In 
general, aspects like: safety, efficacy and /or effectiveness, technical properties, economic 
attributes or impacts and social, legal, ethical or political implications can be also assessed. 
In an attempt to frame MRI reality in Portugal context we are able to see that the lack of 
planning rules has allowed a gap to grow between public and private investments. The western 
area of Portugal is better equipped with doctors, health institutions, and equipment than other 
areas of the country. High-technology equipment is concentrated in the larger cities. The private 
sector is more flexible and prone to innovation. It is the leader in high technology. About 67% of 
larger and more expensive medical equipment is found in the private sector. For example, 1,628 
of the 1,944 haemodialysis machines, 22 of the 27 MRI devices, 83 of the 122 CT scanners, 
and 7 of the 12 lithotripters are in the private sector. Investments in medical equipment were 
limited until about 10 years ago. During the last 10 years, investment has increased. Of all high-
technology equipment currently available in the country, 21% was purchased in the last 5 years 
(Pinto, Ramos and Pereira 2000).  
 
5. Research Methodology 
  
For this study, It will be take into account the population formed by the DM, regarding TA 
decision-making, in MRI context. By setting the sample it is not intended to obtain a statistically 
representative one, but rather a set of personalities who are "socially significant" that allow a 
diversity of opinions, according to Guerra (cf. Guerra 2006). Thus, the sample is selected by 
convenience and according to a set of inclusion and exclusion criteria, to encompass and have 
represented all DM involved.  
In order to frame the whole issue, as an instrument of data gathering, we will use individual 
interviews, semi-structured. According to Marconi and Lakatos (cf. Lakatos and Marconi 2008), 
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in a semi-structured interview, it is given some freedom to the interviewee so that he can 
develop each situation in the direction that he feels most appropriate. The questions are, in 
general open, so that the interviewee can respond according to his opinions, values and 
references. The use of this type of research technique is most appropriate because we want to 
extract qualitative information that allows us to understand the complexity of decision-making 
processes, associated with the use of MR technology and its development. 
The questionnaire will also be used as a tool for collecting data. However this use will only serve 
to collect quantitative data on the technologies and processes used in management of technical 
resources in the area of radiology. It will be built a Guide for the interview so that it can be 
structured and allow some guidance to the researcher, according to the direction of the 
responses given, to conduct the interview in order to achieve the proposed objectives. Briefly, 
there Guide of the interview will consist of 3 main parts: 
I – will address issues related to the interviewee, to allow further social-demographic 
characterization; 
II – will consist of questions that allow the gathering of information relating to issues 
under discussion (will be covered four types of knowledge identified in Figure 3); 
III –will include questions that allow making a summary of the interview, and also 
allowing complete it, drawing some conclusions. 
The data obtained will be of qualitative nature and therefore require an analysis of their own, for 
that content analysis will be the choice, because through it, the investigator has a great capacity 
for interpretation and inference, although running the risks inherent in such research. In this type 
of analysis the framework previously established by the investigator will be confronted with the 
empirical material previously gathered (cf. Guerra 2006). 
 Within the content analysis, the researcher will analyse the data, through categorical analysis, 
which according to Bardin (cf. Bardin 2009), aims to take into account the totality of a "text", 
which is then subjected to a classification and a census, according the frequency of presence 
(or absence) of items of meaning. The quantitative analysis will also be held. 
 
5.1. Framework 
 
The methodology described is intended to answer the following questions: 
 
Q1 In HTA, which decision-makers are involved and what are their points of views? 
Q2 What skills should the decision-makers possess, in the process of decision making during the 
HTA? 
Q3 What procedures should be taken into account in the decision-making process? 
Q4 What indicators are present in decision-making process? What is its priority? 
Q5 What are the factors that may influence the decision-making process from each decision-maker 
point of view? 
Q6 Is there a competitive advantage for HTA, in equipment acquisition? 
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This paper purposes a framework of Technology Governance to study the HTA influence in 
health care, giving as an example the Radiology Department, more specifically the MRI Unit. To 
accomplish the intended of this work, a list of hypothesis was formulated. The analysis of 
responses intended as a framework to accept or refute the research hypotheses: 
 
H1 The HTA in Radiology allows the identification of all decision makers (stakeholders) involved in 
decision making as well as their points of view. These are the decision makers who could be 
members of evaluation panels, as well as participants in future workshops on Radiology. The 
identification of decision makers is a crucial factor, in a successful management model, for this 
technology. 
H2 The more participative the decision-making process is, the more efficient the model of technology 
management becomes. 
H3 The existence of HTA programs for the acquisition of radiological equipment provides greater 
health gains for patients. 
H4 The HTA in Radiology helps to reduce conditions of uncertainty. This process promotes quantity 
and quality HTA information and therefore tends to reduce the uncertainty related to the choice to 
be made (purchase of equipment, introduction or modification of a protocol, terms of use, request 
for replacement, etc.) and decreases the chance of conflict over the decision. 
H5 The presence of HTA programs in health for Radiology, lead to decreased costs in general, since 
the process of decision making is based on evidence (and its management more efficient?). 
 
It is hypothesized that HTA can have a major impact on the process of decision-making, by 
affecting DM points of view. As a consequence health gains will arise (see Figure 5) 
 
 
 
 
Figure 5 - Relationship between the hypothesis 
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The conceptual framework is represented on Figure 6. 
 
 
 
 
Figure 6 - Conceptual Framework 
 
 
The research question previously identified can now be related to some part in the conceptual 
framework: 
 
○ Q1 - A1, A2, A3 
         E1, E2, E3, … 
○ Q2 - those identified in Q1 
○ Q3 - a, b, c, d, e 
○ Q4 - C, A 
○ Q5 - I, II, III, IV 
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Further research will be conducted complete, test and validate the proposed framework on 
Technology Governance in Radiology. 
 
5.2. MRI Equipments 
In order to study the MRI equipment’s in Portugal, an attempted to survey the state of the art 
regarding the existence of this equipment was made. The first step consisted on listing the firms 
that represent this equipment in Portugal. As a result four firms were identified as the 
companies competing in MRI technology marketplace: 
○ Philips 
○ Siemens 
○ General-Electric (GE) 
○ Toshiba 
 
An e-mail was sent to the commercial department asking the total of equipment’s represented 
by each firm and in which sector were they: public or private health sector. As a result the data 
gathered still need confirmation, since the companies gave a non-confirmed answer. GE chose 
not to respond claiming confidentiality of data. 
To overcome the lack of data, a desk research was made combining internet data from clinics, 
hospitals and MRI equipment’s licensed by the General Directorate of Health (DGS). As a result 
of this research there are, regardless of the equipment model (see Table 2) in total, there are 
105 MRI equipments in Portugal, distributed mostly on the private sector. Philips is the leading 
firm in terms of representation. 
 
 
 
Table 2 - MRI equipment distribution in Portugal, by firm and sector 
 
 
Because the GE data is missing, regarding the localization of the MRI equipment (private or 
public sector) it was only possible to analyse in a graphic the weight of each firm in the market 
(Graphic 1): 
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Graphic 1 - MRI equipment distribution by firm 
 
 
In an attempt to study their localizations geographical, using the some data gather (but 
excluding GE information), an attempt for a visual layout was made on Figure 7: 
 
 
 
 
 
Figure 7 - Total geographic distribution of MRI equipment, by firm and sector 
 
 
When analysing the D distribution (Total) it becomes clear that there is a concentration of these 
type of equipment in the north and centre of Portugal, and very few are in the interior. 
Once again it is emphasized the need to deepen and confirm these data. 
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5.3. Identifying and Approaching Decision-Makers 
 
If we considered the general National Health System (NHS) and take into account only the 
Radiology Department (taking MRI as a technology example) we can identify, in a macro view 
some of the DM as well as some of their relationships. These are represented on Figure 8 
 
I  
Figure 8 - Macro representation of the stakeholders and some of their relationships 
 
It is considered “patient” every one that goes to a Radiology Department to make an exam. The 
community it is also considered because we can’t ignore that they have representatives just to 
speak from them, whenever they are questioned and put at risk regarding health. 
We have also the MRI equipment producers and the pharmaceutical that are related with the 
development and production of different technologies complementary to MRI such as contrast 
media. The dealers and the MRI equipment representatives are also decision-makers as well as 
different material suppliers to the Radiology Department. Employees are considered all 
professionals that work in Radiology, especially in the MRI unit. We have also the government, 
who make the laws concerning health protection, technology regulations, equipment’s 
supervision, etc... 
Going on a more micro level, the DM identification and characterization is modified depending 
on the scenario that is being targeted by the study. We will take as an example, an examination 
being done at a Radiology Department, represented in the form of a flowchart (Figure 9): 
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Figure 9 - Flowchart for performing an examination, on a Radiology Department 
 
By analysing the flowchart, we can identify six DM: the Clinician who makes the request for the 
examination, the Administrative (in Radiology Department) that receives the request for the 
examination and shall enter it or will schedule of the same, the Operational Assistant that guides 
the patient from the waiting room to the exam room, where the Radiographer then welcomes 
him and guides him through the exam. Under the guidance (or not) of the Radiologist and the 
support from the Physician Engineering, the Radiographer performs the exam. The exam will 
then follow one of two ways: going straight to the Clinician who requested it or be interpreted 
and reported by the Radiologist before being sent to the Clinician. 
In resume, the DM identified in the example were: 
 
○ Clinician 
○ Administrative 
○ Operational Assistant 
○ Radiographer 
○ Radiologist 
○ Physician Engineering 
If we make the exercise and try to identify the DM involved in Portuguese TA studies, we realise 
that they are essentially health professionals, specially clinicians, whom most of the time have 
the last word regarding decision about the adoption (or not) of new technologies. This opinion is 
shared by Silva and colleagues who also express that due to the lack of knowledge about 
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economic evaluation techniques, these clinicians (who haven’t had health economics as their 
diploma studies) have some difficulties in having economic studies into account (cf. Silva et al. 
2008). 
It is important to make a stakeholder analysis. This analysis will be performed in the future. 
According to the World Health Organization, the Stakeholders Analysis is a technique used to 
identify and assess the importance of key people, groups of people and institutions (World 
Health Organization 2005). There are two general main purposes for the use of this technique: 
first, to identify key stakeholders and assess their interests and influences and second, to 
identify existing networks. 
Professionals should keep their knowledge updated, since at present time it is easy of access to 
information so that they can’t be excluded from dealing with imaging technique, such as 
Magnetic Resonance Imaging. But it is not enough to study and develop these skills. There are 
other skills that should be developed so that the MRI professional does not run the eventuality 
of being or becoming alienated of this technique. Therefore, after the identification of key 
decision makers involved, it will be interesting to understand and identify the skills that these 
decision makers hold (Maia and Moniz 2011). 
 
5.4. Decision-Makers Competences 
 
In order to start and apply a pre-test to a small group of DM, one Radiology Department was 
chosen. As seen previously in a Radiology Department we can find many different DM. To 
understand their competences, it is need to star by understanding their qualifications that are 
necessary and allows them to access their profession and to perform their tasks.  This 
information was resumed in Table 3: 
 
 
DM Training Requirements 
Clinician Mandatory enrolment in College of Radiology, of the Medical Order. 
Technical Assistant (office) 
Trained with the level of education necessary for the proper performance 
of their duties. Computer training is considered essential in a user's 
perspective. 
Operational Assistant Trained with the level of education necessary for the proper performance 
of their duties. 
Radiographer Required official clearance for the profession, according to law. Degree in Radiology. 
Radiologist (Physician) Required registration in the College of Radiology, Order of Doctors. 
Physicist Engineering Required official capacity for the profession, according to law. Degree in Engineering Physics. 
  
Table 3- Training requirements for the different decision-makers in a Radiology Department 
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In the attempt to understand the position of some DM regarding an self-evaluation of their 
competences, a methodology was developed, using as an example only one of the “knowledge” 
previously mentioned in chapter 1.3.1. (Competences for Decision-Making). 
In order to collect some data, a pre-test was applied in a form of a questionnaire in a Radiology 
Department of a central public hospital. 
 
5.4.1. The Pre-Test 
 
To establish the opinion of respondents, a psychometric scale was chosen - the Likert scale. It 
is intended that, when responding to the questionnaire, respondents specify their level of 
agreement with the statement given. The scale went from 1 to 5, meaning:  
 
○ 1 - Few knowledge  
○ 2 - Some knowledge 
○ 3 - General knowledge 
○ 4 - Good knowledge 
○ 5 - Deep knowledge 
In order to establish the component indicators, the information regarding the knowledge per se 
for each of one of the DM in the Radiology Department was gathered. 
After some research, it was possible to find that, from all the four DM analysed only the 
Radiographer has his competences properly well defined. Taking into consideration the 
legislation, concerning the professional career of the Radiographer11 and the Mission Report of 
the Grupo de Trabalho de Radiologia (Radiology Working Group) for the Implementation of the 
Bologna Process (Grupo de Trabalho de Radiologia 2004), the competences profile was 
outlined with the aim of framing the knowledge and skills in performing different tasks. Thereby, 
the information was added to establish a set of skills in an attempt to trace the profile for these 
professional skills, outlining to the following table, only considering the skills level of knowledge 
per se (Table 3): 
 
 
 
 
 
 
 
  
                                               
11
 Decree-Law 564/99, 21 December 
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Competences by area Knowledge in 
Basic Sciences Medical Sciences 
 Physics Sciences 
 Radiobiology 
 Mathematics / Statistics 
 Electronics 
 Management 
 Scientific Investigation 
 Health Sciences / Patient Management 
Scientific Area Sciences Radiation Protection and Safety 
 Quality Assurance 
 Clinical Instrumentation 
Specialty Sciences Clinical Education 
 Methods and Techniques in Radiology 
Complementary disciplines Behavioural Sciences 
 Communication 
 Information Systems 
 
 Table 4 - Radiographer’s knowledge per se by competences areas 
(Based on Mission Report of the Radiology Working Group for the Implementation of the 
Bologna Process, 2004) 
 
For the other DM this characterization was not defined or the information was incomplete. For 
this reason, it was decided to adopt the Radiographer knowledge per se to the pre-test. To keep 
the analysis from becoming too complex and repetitive at this stage, a narrowing of the 
composite indicators number to use was made, having for background the transversal indicators 
for the five DM based on the Radiographers. As a result, seven composite indicators were 
established and identified. 
These are the seven composite indicators that characterize the main indicator “knowledge per 
se”. So that each one can be measured, a statement was established (see Table 5) so that the 
respondents could be able to classify them according to a self-evaluation using the pre-
established Likert Scale.  
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ID Composite Indicator Statement 
Q1 Medical Sciences Knowledge about the structure, function and disease pattern of the human 
body. Includes knowledge of anatomy, physiology, pathology, biochemistry, 
etc... 
Q2 Physical Sciences General knowledge of radiation physics, required for implementing the various 
forms of imaging technologies. 
Q3 Radiobiology and Radiation 
Protection 
Knowledge for understanding the effects of radiation on the human body as 
well as radiological protection and safety. 
Q4 Electronics and Clinical 
Instrumentation   
Knowledge about the principles and operation of electronic devices and 
understanding of the equipment used in Radiology (MRI area) so that they can 
be used. 
Q5 Management and 
Administration 
Knowledge about different areas of management and administration 
techniques (knowledge in principles, techniques, and administrative tools, 
planning, organizing, leading, ensuring quality control, etc.). 
Q6 Communication and 
Behavioural Sciences 
Knowledge that allow interacting / acting effectively in various situations as well 
as knowledge about the development and understanding of human behaviour 
at both sociological and psychological level. 
Q7 Information Systems Knowledge of the principles relating to the operation of computers and 
associated technology. 
 
Table 5 - Composite indicator and statements for the Knowledge per se 
 
The questionnaire for the pre-test was then made.  
 
5.4.2. The Analysis 
 
The collected data was analysed, using the computer program EXCEL 2007 and the results 
represented in radar referential, with 7 vertices’ each correspond to one of the seven composite 
indicators previously identified. 
 
5.4.2.1. Characterization of the sample 
 
The questionnaire was applied to 39 main decision-makers with the following distribution: 
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Graphic 2 - Decision-makers distribution on the pre-test 
 
The majority of the DM, work with MRI equipment only in the public health sector (90 %) and 
only 5 % work simultaneously in the public and in the private sector. None of the interviewed 
only work with MRI in the private sector. Two of the interviewed didn’t answer the question. 
The average age of the interviewed was 37.7 years and they are mainly females (25, which 
represent 64%). Only 14 interviewed were male (see Graphic 3). 
 
 
 
 
Graphic 3 - Sample’s distribution according to gender 
 
Regarding the academic qualifications (Graphic 4), 3 DM have the 6th scholar year (8 %), 2 
have the 9th scholar year (5 %), only 1 have the  11th scholar year (3 %), 7 have the 12th 
scholar year (18 %), 2 accomplished  a bachelor (5 %) and 24 DM (61 %) have a graduation. 
This imply that these 24 DM are the only one’s who have  an academic degree and since 
Radiographers and Radiologist are the only DM who must have an academic degree to fulfill 
their roles, this 61 % of interviewed correspond to them, with one exception: there is one 
Technical Assistant with a graduation. 
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Graphic 4 - Sample’s distribution according to academic qualification 
 
In average, the 39 DM have been working in Radiology department for 12 years and present 4 
years of working within MRI. Because this is a recent technology with so many specifications we 
can assist to this gap between the years of experience in Radiology and the years with MRI 
experience, not all professional can have access to work with these technology. 
 
 
5.4.2.2. Characterization of the knowledge 
 
In order to characterize the seven composite indicators, the data gathered from the answers 
given, were represented in radar graphic, where each of the radar branch correspond to a 
composite indicator. 
 
Graphic 5 shows one radar graphic for each one of the DM. 
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Graphic 5 - Radar graphic for each decision-maker 
 
As we can see, some indicators appear closer to the referential centre and some are positioned 
far from it. When we look to the Radiographer’s radar it is evident that there is uniformity on the 
results, since the radar is constant, without many pronounced vertices’. However Q3 
(Radiobiology and Radiation Protection) shows a more prominent point, in congruence with the 
knowledge expected for this DM.  
Regarding the Radiologist, Q1, Q6 and Q7 can be identified with the highest knowledge and the 
rest indicators stay more or less equal. Taking into account the background knowledge for these 
DM, it was expected that Q1 (Medical Sciences) appeared with the highest note - 5 (deep) - 
instead it appears with 4 (good).  
The Operational Assistant radar also shows some uniform results. Q5 and Q6 have exactly the 
some score and Q3 and Q4 despite though slightly higher also present the some score as the 
previous one´s - general knowledge. Q7, 1 and 2 results are similar and classified as “some 
knowledge”. In general results for this DM, and taking also into account his knowledge per se 
background it was unexpected the results for indicator Q3, 4 and 5 as for Q1 and 2. 
For the Technical Assistant, Q3, 5, 6 and 7 present slightly the some result - 3 (general 
knowledge)) - and the some goes to Q1, 2 and 4 with the result 2 (some knowledge) which 
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indicates a homogenization regarding all knowledge. To have a more clear perspective of the 
global positioning, the combination of all four referential was made (Graphic 6).  
 
 
 
 
Graphic 6 - Global Radar graphic for all decision-makers 
 
By looking at this global representation we can see that it is in Q1, Q7, Q2 and Q3 that the DM 
positioned themselves away from each other. On the opposite, in Q5 and Q6 some points are 
overlapping. This fact indicates that for the first group of composite indicators, the knowledge of 
each group of DM tends to be differentiated. The opposite is applied for the second group, 
where the knowledge is more alike and it seems to exist some standardization in the answers 
given. 
By taking into consideration the Likert scale previously defined, where 5 corresponds to a deep 
knowledge, the more dispersed the representation is, more specialized the knowledge tend to 
be, associated to the composite indicator. If we make an analysis taking this into consideration, 
Radiologist distance themselves from the other DM in Q1, Q7 and Q6 as this points are 
dispersed in relation to the others, which indicates that Radiologist present a more differentiated 
knowledge concerning Medical Sciences, Communication and Behavioural Sciences and 
Information Systems. On the other hand, Radiographers distinguish themselves when it 
concerns Physical Sciences and Radiobiology and Radiation Protection knowledge (composite 
indicator Q2 and Q3 respectively). 
The other DM do not present a distinguished knowledge, in general terms. To make a more 
precise analysis, the average for each one of the composite indicator, according to the 
respondent, was calculated and then compared to a weighted average of all the collected data 
(Table 6). 
37 
 
 
Table 6- Results of the pre-test according to the calculated average 
 
From the analysis of Table 6, some of the results captured our attention:  
• For Q1 and Q2 the results tend to mach the reality, has only the Radiologist and 
Radiographer have the necessary knowledge to stay above average, concerning 
medical and physical sciences knowledge. 
• It is interesting to see that, for Q3 the Radiologist positioned themselvs below average. 
This kind of knowledge should be present for Radiologist, since they are also 
responsible (along with the Radiographer) to respect the ALARA principle (as low as 
reasonable achievable) concerning the radiation dose necessary to acquire quality 
images in the exam. 
• Surprisingly the answers given regarding Q4 and Q5 positioned the Operational 
Assistant above the average. This specific knowledge is not given to this professional, 
since there aren’t compulsory education to became an Operational Assistant. 
• Management and Administration (Q5) are two major disciplines in the degree of 
Radiology, so it is surprising that the answers given by the Radiographers are positioned 
below the average. The some goes to Q4, since Electronics and Clinic Instrumentation 
are also specific disciplines of the course and for that Radiographers should positioned 
themselvs above the average. 
• Regarding Q6 (Communication and Behavioural Science), although the Operational 
Assistant and the Radiographer possess expertise in this area, these two professionals 
should not be located on the same level compared with the average, in other words, 
there should be a distinction between these two professional position, since the 
Operational Assistant does not have prior theoretical knowledge, while the 
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Radiographer, has such knowledge since the same is provided in the university, while 
gaining his academic qualification. 
 
 
6. Discussion   
 
Some critics have already been made to this project. All of them were analysed and 
summarised so that they can be taken into account into the continuing project work. 
The critics and suggestions were bulleted: 
● Characterization of the National Portuguese Health System - The characterization of the 
National Portuguese Health System is needed in order to framework some issues and to 
have a better understanding regarding the public versus private health system and the 
access to some medical  care (for example the MRI exams) 
● Characterization of the MRI equipment status in Portugal - so that a clear 
characterization of the equipment can be develop, taking into account the geographical 
distributions of the equipment’s, it’s distribution in private and public sector, etc... 
● Characterization of the chain value - the identification of the main stakeholders is need 
so that a chain value can be characterized. The relations between stakeholders have to 
be defined as well as the competences of each one in the process of decision making. 
All the data gathered works like an incentive to the following work that has to be done.... In order 
to characterize the chain value, a decision-maker (or stakeholders) mapping has to be done.  
The data gathered concerning the MRI equipment have showed that there is still a gap between  
the private and public sector, in terms of MRI equipment, and that the western part of Portugal, 
is still the best equipped. These data need to be more precise and developed. 
The questionnaire applied for the knowledge per se need to be applied to a national level and 
the other three types of knowledge need to be pre-tested and also applied to  national level. 
These are only some of the task that is waiting to be worked upon. 
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